Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 63 articles:
HTML format
Text format



Single Articles


    August 2019
  1. SERIN A, Tokat Y
    Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease.
    Transplant Proc. 2019 Aug 9. pii: S0041-1345(18)31750.
    PubMed     Text format     Abstract available


  2. SERIN A, Sahin T, Emek E, Arikan T, et al
    Role of Preoperative Viral Load and Presence of Hepatocellular Carcinoma in the Biliary Complications After Liver Transplantation Due to Hepatitis C Virus.
    Transplant Proc. 2019 Aug 9. pii: S0041-1345(19)30242.
    PubMed     Text format     Abstract available


  3. SAHIN T, Serin A, Emek E, Bozkurt B, et al
    Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis.
    Transplant Proc. 2019 Aug 8. pii: S0041-1345(18)31711.
    PubMed     Text format     Abstract available


    July 2019
  4. MENG C, Liu T, Liu YW, Zhang LZ, et al
    Hepatitis B Virus cccDNA in Hepatocellular Carcinoma Tissue Increases the Risk of Recurrence After Liver Transplantation.
    Transplant Proc. 2019 Jul 26. pii: S0041-1345(19)30497.
    PubMed     Text format     Abstract available


    May 2019
  5. DUNDAR HZ, Aksoy F, Aksoy SA, Tasar P, et al
    Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Transplant Proc. 2019;51:1157-1161.
    PubMed     Text format     Abstract available


    April 2019
  6. NUGROHO A, Lee KW, Kim H, Yi NJ, et al
    De Novo Hepatitis B Virus Infection After Liver Transplantation in Hepatitis B Core-positive Recipients Using Hepatitis B Core-negative Grafts.
    Transplant Proc. 2019;51:842-844.
    PubMed     Text format     Abstract available


  7. FAUST I, Weile J, Fujita B, Kandolf R, et al
    Heart Transplantation in Systemic Sclerosis: New Impulses for Conventional Scleroderma Transplantation Regimen and Scleroderma Diagnostic Monitoring: 2 Case Reports.
    Transplant Proc. 2019;51:865-870.
    PubMed     Text format     Abstract available


    March 2019
  8. SINGH D, Hassan M, Lim N
    Reactivation of Hepatitis B Virus Infection With Reverse Seroconversion Following Umbilical Cord Allogeneic Hematopoietic Cell Transplantation in a Hepatitis-B-Immune Patient: A Case Report.
    Transplant Proc. 2019;51:602-604.
    PubMed     Text format     Abstract available


  9. AMBROCIO GPL, Aguado S, Carrillo J, Laporta R, et al
    Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series.
    Transplant Proc. 2019;51:376-379.
    PubMed     Text format     Abstract available


    February 2019
  10. ACAR S, Gencdal G, Kirimlioglu H, Polat KY, et al
    Varicella-Zoster Virus-Induced Hepatitis in a Liver Transplant Recipient: A Case Report.
    Transplant Proc. 2019 Feb 8. pii: S0041-1345(18)31720.
    PubMed     Text format     Abstract available


    December 2018
  11. WONG TCL, Fung JYY, Chok KSH, Cheung TT, et al
    Hepatitis B Vaccination in Patients Receiving Oral Antiviral Therapy Without Hepatitis B Immunoglobulin After Liver Transplant.
    Transplant Proc. 2018;50:3681-3688.
    PubMed     Text format     Abstract available


  12. SUNDARAM V, Wu T, Klein AS, Noureddin M, et al
    Liver Transplantation for Severe Alcoholic Hepatitis: Report of a Single Center Pilot Program.
    Transplant Proc. 2018;50:3527-3532.
    PubMed     Text format     Abstract available


  13. NG C, Danguilan R, Pamugas G, Que E, et al
    Outcomes of Renal Allograft Recipients With Hepatitis B From January 2000 to December 2010.
    Transplant Proc. 2018;50:3242-3248.
    PubMed     Text format     Abstract available


    November 2018
  14. JUNG BH, Park JI, Lee SG
    Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case Report.
    Transplant Proc. 2018;50:2877-2881.
    PubMed     Text format     Abstract available


  15. HUANG TL, Chen TY, Tsang LC, Ou HY, et al
    Acoustic Radiation Force Impulse Elastography in Post-transplant Recurrent Hepatitis C in Living Donor Liver Transplantation.
    Transplant Proc. 2018;50:2695-2698.
    PubMed     Text format     Abstract available


  16. LIN LM, Kuo SC, Chiu YC, Lin HF, et al
    Cost Analysis and Determinants of Living Donor Liver Transplantation in Taiwan.
    Transplant Proc. 2018;50:2601-2605.
    PubMed     Text format     Abstract available


    September 2018
  17. WOJTOWICZ M, Wilkowski P, Hryniewiecka E, Cieciura T, et al
    Effect of Successful Treatment of Hepatitis C Virus Infection Recurrence With Direct-Acting Antiviral Agents on Physical Performance in Liver Transplant Recipients.
    Transplant Proc. 2018;50:2027-2030.
    PubMed     Text format     Abstract available


    July 2018
  18. PLISZCZYNSKI J, Jasztal K, Jozwik A, Kosieradzki M, et al
    Results of Renal Transplant From Deceased Anti-hepatitis C Virus Donors, Poland 1998-2012.
    Transplant Proc. 2018;50:1691-1696.
    PubMed     Text format     Abstract available


  19. WAZNA E, Pazik J, Perkowska-Ptasinska A, Durlik M, et al
    Does Histopathology of Implanted Kidney According to Banff 07 Help Predict Long-term Transplantation Outcome?
    Transplant Proc. 2018;50:1765-1768.
    PubMed     Text format     Abstract available


    June 2018
  20. GARCIA-PAJARES F, Tejedor-Tejada J, Torres-Yuste R, Almohalla-Alvarez C, et al
    Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30877.
    PubMed     Text format     Abstract available


  21. RAYA AM
    Influence of Donor Obesity on Long-Term Liver Transplantation Outcomes.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30837.
    PubMed     Text format     Abstract available


  22. KWON JH, Hanouneh IA, Allende D, Yerian L, et al
    De Novo Autoimmune Hepatitis Following Liver Transplantation.
    Transplant Proc. 2018;50:1451-1456.
    PubMed     Text format     Abstract available


  23. PESCHEL G, Moleda L, Baier L, Selgrad M, et al
    Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post-Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response-A Single-Center Study.
    Transplant Proc. 2018;50:1444-1450.
    PubMed     Text format     Abstract available


  24. BODRO M, Sanclemente G, Crespo G, Linares L, et al
    Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients.
    Transplant Proc. 2018;50:1437-1443.
    PubMed     Text format     Abstract available


  25. WAHAB MA, Shehta A, Elshoubary M, Yassen AM, et al
    Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single Center.
    Transplant Proc. 2018;50:1396-1406.
    PubMed     Text format     Abstract available


    April 2018
  26. IMAI H, Kamei H, Onishi Y, Ishizu Y, et al
    Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus.
    Transplant Proc. 2018 Apr 25. pii: S0041-1345(18)30211.
    PubMed     Text format     Abstract available


  27. ORUC A, Ersoy A
    Transplantation Opportunities of Hepatitis C Virus-Seropositive Patients on the Kidney Waiting List.
    Transplant Proc. 2018 Apr 18. pii: S0041-1345(18)30614.
    PubMed     Text format     Abstract available


  28. TAKEUCHI S, Takamura M, Yoshida T, Takahashi K, et al
    Ombitasvir-Paritaprevir-Ritonavir Therapy in a Kidney Transplant Recipient With Chronic Hepatitis C Virus Genotype 1 Infection: A Case Report on the Importance of Considering Drug-Drug Interactions and Monitoring Cyclosporine Levels.
    Transplant Proc. 2018;50:884-886.
    PubMed     Text format     Abstract available


  29. WEIGERT A, Querido S, Carvalho L, Lebre L, et al
    Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.
    Transplant Proc. 2018;50:743-745.
    PubMed     Text format     Abstract available


  30. MUCENIC M, Bandeira de Mello Brandao A, Marroni CA, Medeiros Fleck A Jr., et al
    Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World Study.
    Transplant Proc. 2018;50:769-771.
    PubMed     Text format     Abstract available


  31. MARTINO RB, Waisberg DR, Dias APM, Inoue VBS, et al
    Stratifying Mortality in a Model for End-Stage Liver Disease Waiting List: A Brazilian Single-Center Study.
    Transplant Proc. 2018;50:758-761.
    PubMed     Text format     Abstract available


    March 2018
  32. TENORIO GONZALEZ E, Robles Diaz M, Sanjuan Jimenez R, Gonzalez Grande R, et al
    Retransplant Due to Fulminant Hepatic Failure From Hepatitis E Virus: A Case Report.
    Transplant Proc. 2018;50:685-686.
    PubMed     Text format     Abstract available


  33. NOGUERAS LOPEZ F, Lopez Garrido A, Ortega Suazo EJ, Vadillo Calles F, et al
    Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients.
    Transplant Proc. 2018;50:631-633.
    PubMed     Text format     Abstract available


  34. CAICEDO LA, Delgado A, Garcia VH, Aristizabal AM, et al
    Liver Transplantation in Hepatitis C-Infected Patients: Experience From a South American Transplant Center.
    Transplant Proc. 2018;50:493-498.
    PubMed     Text format     Abstract available


    January 2018
  35. MIUMA S, Miyaaki H, Miyazoe Y, Suehiro T, et al
    Development of Duodenal Ulcers due to the Discontinuation of Proton Pump Inhibitors After the Induction of Sofosbuvir Plus Ledipasvir Therapy: A Report of Two Cases.
    Transplant Proc. 2018;50:222-225.
    PubMed     Text format     Abstract available


    December 2017
  36. MOTOMURA T, Yoshizumi T, Ohira M, Mano Y, et al
    Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:2409-2410.
    PubMed     Text format     Abstract available


    November 2017
  37. TOWNSEND SA, Monga MA, Nightingale P, Mutimer D, et al
    Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
    Transplant Proc. 2017;49:2129-2134.
    PubMed     Text format     Abstract available


  38. ROULLET S, Defaye M, Quinart A, Adam JP, et al
    Liver Transplantation With Old Grafts: A Ten-Year Experience.
    Transplant Proc. 2017;49:2135-2143.
    PubMed     Text format     Abstract available


    October 2017
  39. FREY A, Ecker EM, Piras-Straub K, Walker A, et al
    Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
    Transplant Proc. 2017;49:1947-1955.
    PubMed     Text format     Abstract available


  40. LIAO HT, Tan P, Huang JW, Yuan KF, et al
    Ledipasvir + Sofosbuvir for Liver Transplant Recipients With Recurrent Hepatitis C: A Systematic Review and Meta-analysis.
    Transplant Proc. 2017;49:1855-1863.
    PubMed     Text format     Abstract available


    September 2017
  41. SHAFII AE, Harris DD 2nd, Baz M
    Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case Report.
    Transplant Proc. 2017;49:1682-1684.
    PubMed     Text format     Abstract available


  42. NAKANO R, Ohira M, Ishiyama K, Ide K, et al
    Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:1634-1638.
    PubMed     Text format     Abstract available


    July 2017
  43. TRONINA O, Slubowska K, Mikolajczyk-Korniak N, Komuda-Leszek E, et al
    Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature Review.
    Transplant Proc. 2017;49:1409-1418.
    PubMed     Text format     Abstract available


    June 2017
  44. OHIRA M, Nishida S, Tryphonopoulos P, Ruiz P, et al
    Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication.
    Transplant Proc. 2017;49:1160-1164.
    PubMed     Text format     Abstract available


  45. CHO CW, Kwon CHD, Kim JM, Choi GS, et al
    Comparative Analysis of the Clinical Outcomes of Liver Transplantation for Probable and Definite Auto-immune Hepatitis by International Diagnostic Scoring Criteria.
    Transplant Proc. 2017;49:1126-1128.
    PubMed     Text format     Abstract available


  46. KOSHINO K, Ushigome H, Masuda K, Matsuyama T, et al
    Effective Treatment With Daclatasvir and Asunaprevir in Kidney Transplant Patients Infected With Hepatitis C Virus: A Report of Two Cases.
    Transplant Proc. 2017;49:1053-1055.
    PubMed     Text format     Abstract available


  47. YU YD, Kim DS, Han JH, Yoon YI, et al
    Successful Treatment of a Patient With Diffuse Portosplenomesenteric Thrombosis Using a Pericholedochal Varix for Portal Flow Reconstruction During Deceased Donor Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:1202-1206.
    PubMed     Text format     Abstract available


    May 2017
  48. PIAI G, Miglioresi L, Valente G
    Eradication of Hepatitis C After Liver Transplantion: Consequences for the Organization of the Transplant Patient's Follow-up.
    Transplant Proc. 2017;49:671-673.
    PubMed     Text format     Abstract available


  49. TRAPANI S, Rizzato L, Masiero L, Ricci A, et al
    Hepatitis C Virus Positive Patients on the Waiting List for Liver Transplantation: Turnover and Characteristics of the Population on the Eve of the Therapeutic Revolution With Direct-Acting Antivirals.
    Transplant Proc. 2017;49:658-666.
    PubMed     Text format     Abstract available


    April 2017
  50. ULKU A, Akcam AT, Rencuzogullari A, Dalci K, et al
    Effect of Dosage and Type of Hepatitis B Immunoglobulin on Hepatitis Antibody Levels in Liver Transplant Recipients.
    Transplant Proc. 2017;49:575-579.
    PubMed     Text format     Abstract available


    January 2017
  51. MELLO F, Girao C, Castro CC, Fiuza S, et al
    De Mello's Single Incision for Combined Liver-kidney Transplantation, Keeping the Kidney Retroperitoneal: A Case Report.
    Transplant Proc. 2017;49:169-171.
    PubMed     Text format     Abstract available


    November 2016
  52. CHOI S, Kim KK, Lee WS, Kang JM, et al
    Living Donor Liver Transplantation in a Patient With Extensive Portomesenteric Venous Thrombosis: Case Report.
    Transplant Proc. 2016;48:3153-3155.
    PubMed     Text format     Abstract available


  53. GARCIA BERNARDO CM, Arguelles Garcia B, Redondo Buil P, Miyar de Leon A, et al
    Collateral Development in Thrombosis of the Hepatic Artery After Transplantation.
    Transplant Proc. 2016;48:3006-3009.
    PubMed     Text format     Abstract available


  54. SAFWAN M, Nagai S, Abouljoud MS
    Portal Vein Inflow From Enlarged Coronary Vein in Liver Transplantation: Surgical Approach and Technical Tips: A Case Report.
    Transplant Proc. 2016;48:3070-3072.
    PubMed     Text format     Abstract available


  55. CEPEDA-FRANCO C, Bernal-Bellido C, Barrera-Pulido L, Alamo-Martinez JM, et al
    Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
    Transplant Proc. 2016;48:2983-2986.
    PubMed     Text format     Abstract available


    October 2016
  56. ALDEMIR E, Coskunol H, Kilic M, Sert I, et al
    Treatment of Opioid Dependence With Buprenorphine/Naloxone After Liver Transplantation: Report of Two Cases.
    Transplant Proc. 2016;48:2769-2772.
    PubMed     Text format     Abstract available


    September 2016
  57. BENITEZ-GUTIERREZ L, de Mendoza C, Banos I, Duca A, et al
    Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir.
    Transplant Proc. 2016;48:2515-2518.
    PubMed     Text format     Abstract available


  58. TEIXEIRA HR, Marques DM, Lopes AR, Ziviani LC, et al
    Anxiety and Stress Levels on Liver Transplantation Candidates.
    Transplant Proc. 2016;48:2333-2337.
    PubMed     Text format     Abstract available


  59. MONTE DA SILVA AG, deA Roza Aguiar B, Chiavegato LD
    Association Between Dyspnea and Severity of Liver Disease in Patients in the Pre-transplantation Period-A Pilot Study.
    Transplant Proc. 2016;48:2328-2332.
    PubMed     Text format     Abstract available


  60. DE FELICIO HC, da Silva RC, da Costa AM, Arroyo PC Jr, et al
    Family Members, Transplantation Candidates, and Patients Who Underwent Liver Transplantation Had Insufficient Information About the Procedure.
    Transplant Proc. 2016;48:2323-2327.
    PubMed     Text format     Abstract available


    June 2016
  61. WASIAK D, Jonas M, Lagiewska B, Cieciura T, et al
    Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report.
    Transplant Proc. 2016;48:1855-7.
    PubMed     Text format     Abstract available


  62. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Transplant Registry in Poland: Web-Netted Quality Tool in Liver Transplantation From Deceased and Living Donors.
    Transplant Proc. 2016;48:1347-9.
    PubMed     Text format     Abstract available


  63. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Donation and Transplantation in Poland: Numbers, Indicators, and Trends.
    Transplant Proc. 2016;48:1341-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: